J.K. Joung, et al. TALENs: a widely applicable technology for targeted genome editing. Nature Reviews Molecular Cell Biology. 2013 Jan. doi:10.1038/nrm3486.

Nov

17

Editas Medicine Announces Clinical Data Demonstrating Proof of Concept of EDIT-101 from Phase 1/2 BRILLIANCE Trial

Nov

2

Editas Medicine Announces Third Quarter 2022 Results and Business Updates

Oct

26

Editas Medicine to Host Conference Call Discussing Third Quarter 2022 Results and Corporate Update